Auctus Advisors »

Perspective Therapeutics shares owned by Auctus Advisors

Quarter-by-quarter ownership of Perspective Therapeutics (CATX) shares owned by Auctus Advisors from 13F filings

Historical chart of Auctus Advisors investment in Perspective Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Perspective Therapeutics held by Auctus Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Perspective Therapeutics by Auctus Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $87k 32k 2.75

More positions owned by Auctus Advisors

Putnam Etf Trust Focused Lar Cap (PVAL)
Harbor Etf Trust Long Term Grower (WINN)
Apple (AAPL)
Microsoft Corporation (MSFT)
Spdr Gold Tr Gold Shs (GLD)
Alphabet Cap Stk Cl C (GOOG)
Colgate-Palmolive Company (CL)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
JPMorgan Chase & Co. (JPM)
NVIDIA Corporation (NVDA)
Capital Group Core Equity Et Shs Creation Uni (CGUS)
Owens Corning (OC)
Broadcom (AVGO)
Ishares Tr Core Msci Eafe (IEFA)
Schwab Strategic Tr Us Lcap Gr Etf (SCHG)

View all positions for Auctus Advisors

Top funds holding Perspective Therapeutics

FMR
BlackRock
Vanguard Group
Avidity Partners Management
Millennium Management
Nicholson Wealth Management Group
Geode Capital Management
Nuveen
State Street Corporation
Hills Bank And Trust Company
UBS Group
Walleye Trading Advisors
Charles Schwab Investment Management
Two Sigma Investments
Sphera Funds Management

View all funds holding Perspective Therapeutics